 Their early work considered the development of Influenza A virus subtype H1N1 and H5N1 virus-like particle pandemic influenza vaccines.Virus-like particle vaccines offer immunogenic, strain-specific recombinant antigens that can be produced at scale.In 2008 Neuzil was made Chair of the Infectious Diseases Society of America Pandemic Influenza Task Force.